X-150469795-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005491.5(MAMLD1):c.222G>A(p.Met74Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000271 in 110,829 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 22)
Consequence
MAMLD1
NM_005491.5 missense
NM_005491.5 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 5.04
Genes affected
MAMLD1 (HGNC:2568): (mastermind like domain containing 1) This gene encodes a mastermind-like domain containing protein. This protein may function as a transcriptional co-activator. Mutations in this gene are the cause of X-linked hypospadias type 2. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAMLD1 | NM_005491.5 | c.222G>A | p.Met74Ile | missense_variant | 4/8 | ENST00000370401.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAMLD1 | ENST00000370401.7 | c.222G>A | p.Met74Ile | missense_variant | 4/8 | 5 | NM_005491.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110829Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33043
GnomAD3 genomes
AF:
AC:
3
AN:
110829
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33043
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110829Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33043
GnomAD4 genome
AF:
AC:
3
AN:
110829
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33043
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.222G>A (p.M74I) alteration is located in exon 3 (coding exon 3) of the MAMLD1 gene. This alteration results from a G to A substitution at nucleotide position 222, causing the methionine (M) at amino acid position 74 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;D;T;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;M
MutationTaster
Benign
N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;D;N;N
REVEL
Benign
Sift
Benign
T;D;D;T;T
Sift4G
Benign
T;T;D;T;T
Polyphen
D;P;.;D;D
Vest4
MutPred
Loss of disorder (P = 0.0578);.;Loss of disorder (P = 0.0578);.;Loss of disorder (P = 0.0578);
MVP
MPC
0.56
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at